Evan Levine, CEO & President at ADVENTRX PHARMACEUTICALS INC (ANX), bought 5,000 shares at $0.51 ($3K) on 2008-02-08, disclosed to the SEC on 2008-04-15.
Open-market purchase of $3k ANX by CEO & President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.50 | 2,000 | $1K | 39.5% |
| 2 | $0.51 | 3,000 | $2K | 60.5% |
| Total | $0.51 avg | 5,000 | $3K | 100% |
| Filing → |
| ANX | SELL | 2008-04-15 | $34K | — | Filing → |
| ANX | BUY | 2007-12-17 | $27K | — | Filing → |
| QTXB | SELL | 2007-02-09 | $559K | — | Filing → |